Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Siddle

Showing results (91-100 of 113) with videos related to

Pageof 12
Sort By:
The Biochemical Journal|November 15, 1992
A monoclonal anti-peptide antibody reacting with the insulin receptor beta-subunit. Characterization of the antibody and its epitope and use in immunoaffinity purification of intact receptorsR H Ganderton, K K Stanley, C E Field, et al.
Breast Cancer Research and Treatment|March 5, 1999
Insulin-like growth factors in human breast cancerM J Ellis, S Jenkins, J Hanfelt, et al.
Biochemical Society Transactions|August 11, 2001
Specificity in ligand binding and intracellular signalling by insulin and insulin-like growth factor receptorsK Siddle, B Ursø, C A Niesler, et al.
The Journal of Clinical Investigation|July 1, 1995
Mechanism of insulin receptor kinase inhibition in non-insulin-dependent diabetes mellitus patients. Phosphorylation of serine 1327 or threonine 1348 is unalteredM Kellerer, M Coghlan, E Capp, et al.
The Biochemical Journal|June 15, 1987
The preparation of monoclonal antibodies to human bone and liver alkaline phosphatase and their use in immunoaffinity purification and in studying these enzymes when present in serumE M Bailyes, R N Seabrook, J Calvin, et al.
Circulation Research|May 23, 2001
Defect in insulin-like growth factor-1 survival mechanism in atherosclerotic plaque-derived vascular smooth muscle cells is mediated by reduced surface binding and signalingV A Patel, Q J Zhang, K Siddle, et al.
The Biochemical Journal|April 1, 1986
Monoclonal antibodies reacting with multiple epitopes on the human insulin receptorM A Soos, K Siddle, M D Baron, et al.
The Journal of Biological Chemistry|October 16, 1999
Differences in signaling properties of the cytoplasmic domains of the insulin receptor and insulin-like growth factor receptor in 3T3-L1 adipocytesB Ursø, D L Cope, H E Kalloo-Hosein, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 1989
Monoclonal antibodies to the insulin receptor mimic metabolic effects of insulin but do not stimulate receptor autophosphorylation in transfected NIH 3T3 fibroblastsM A Soos, R M O'Brien, N P Brindle, et al.
Endocrinology|January 23, 2003
Deletion of V335 from the L2 domain of the insulin receptor results in a conformationally abnormal receptor that is unable to bind insulin and causes Donohue's syndrome in a human subjectS George, A Johansen, M A Soos, et al.
Pageof 12

Showing results (91-100 of 113) with videos related to

Sort By:
Pageof 12
The Biochemical Journal|November 15, 1992
A monoclonal anti-peptide antibody reacting with the insulin receptor beta-subunit. Characterization of the antibody and its epitope and use in immunoaffinity purification of intact receptorsR H Ganderton, K K Stanley, C E Field, et al.
Breast Cancer Research and Treatment|March 5, 1999
Insulin-like growth factors in human breast cancerM J Ellis, S Jenkins, J Hanfelt, et al.
Biochemical Society Transactions|August 11, 2001
Specificity in ligand binding and intracellular signalling by insulin and insulin-like growth factor receptorsK Siddle, B Ursø, C A Niesler, et al.
The Journal of Clinical Investigation|July 1, 1995
Mechanism of insulin receptor kinase inhibition in non-insulin-dependent diabetes mellitus patients. Phosphorylation of serine 1327 or threonine 1348 is unalteredM Kellerer, M Coghlan, E Capp, et al.
The Biochemical Journal|June 15, 1987
The preparation of monoclonal antibodies to human bone and liver alkaline phosphatase and their use in immunoaffinity purification and in studying these enzymes when present in serumE M Bailyes, R N Seabrook, J Calvin, et al.
Circulation Research|May 23, 2001
Defect in insulin-like growth factor-1 survival mechanism in atherosclerotic plaque-derived vascular smooth muscle cells is mediated by reduced surface binding and signalingV A Patel, Q J Zhang, K Siddle, et al.
The Biochemical Journal|April 1, 1986
Monoclonal antibodies reacting with multiple epitopes on the human insulin receptorM A Soos, K Siddle, M D Baron, et al.
The Journal of Biological Chemistry|October 16, 1999
Differences in signaling properties of the cytoplasmic domains of the insulin receptor and insulin-like growth factor receptor in 3T3-L1 adipocytesB Ursø, D L Cope, H E Kalloo-Hosein, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 1989
Monoclonal antibodies to the insulin receptor mimic metabolic effects of insulin but do not stimulate receptor autophosphorylation in transfected NIH 3T3 fibroblastsM A Soos, R M O'Brien, N P Brindle, et al.
Endocrinology|January 23, 2003
Deletion of V335 from the L2 domain of the insulin receptor results in a conformationally abnormal receptor that is unable to bind insulin and causes Donohue's syndrome in a human subjectS George, A Johansen, M A Soos, et al.
Pageof 12